PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
21-Apr-2024 Agenda Announced for Semantic Data 2024: Taxonomy, Ontology, and Knowledge Graphs conference in London Henry Stewart Events
18-Apr-2024 Beckman Coulter Life Sciences Launches QbD1200+ Total Organic Carbon Analyzer Beckman Coulter Life Sciences
18-Apr-2024 BC Platforms and NTT Group Announce Official Opening Ceremony for Exclusive Collaboration and Launch of Japanese Precision Medicine Platform BC Platforms (BCP)
11-Apr-2024 AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock AdrenoMed AG
11-Apr-2024 Sanofi announces launch of Verorab® (Sanofi Inactivated Rabies Vaccine) in the UK for pre-exposure and post-exposure prophylaxis of rabies in all age groups Sanofi
11-Apr-2024 CRISPR-based innovations drive $21 billion in pharmaceutical licensing deals over five years, reveals GlobalData GlobalData
11-Apr-2024 ROM InWest invests €1.5 million into AI and computer vision company Kepler Vision Technologies Kepler Vision Technologies
11-Apr-2024 New insight into combatting drug-resistant prostate cancer University of Eastern Finland
11-Apr-2024 Cambridge Cognition strengthens senior management team to deliver growth Cambridge Cognition Holdings plc
11-Apr-2024 Bayer and Google Cloud Collaborate to Bring Responsible AI Solutions to Radiologists Bayer
11-Apr-2024 Qinecsa Host Industry Discussion on Mastering Medical Device Regulations to Integrate Devices into Pharma Portfolios Qinecsa
11-Apr-2024 AbbVie’s AQUIPTA® (atogepant) Is Recommended By NICE For The Prevention Of Migraine In Adults AbbVie
11-Apr-2024 Modus Therapeutics Holding AB (publ) publishes annual report for the financial year 2023 Modus Therapeutics Holding AB
11-Apr-2024 The Power of Oral Appliances: Navigating the Sleep Apnea Market Markets and Markets
09-Apr-2024 Veklury (remdesivir) recommended by NICE for treatment of COVID-19 in vulnerable adults and children Gilead
09-Apr-2024 Gilead extends partnership with NHS England to eliminate hepatitis C by 2025 Gilead
09-Apr-2024 Green Elephant Biotech expands sustainable 96-well plate line for light-sensitive experiments Green Elephant Biotech
09-Apr-2024 Gilead extends partnership with NHS England to eliminate hepatitis C by 2025 Gilead Sciences, Inc
09-Apr-2024 Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors Mestag Therapeutics
09-Apr-2024 PureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions PureTech Health plc